MYL3 Antibody (N-term)
Affinity Purified Rabbit Polyclonal Antibody (Pab)
- 产品详情
- 实验流程
- 背景知识
Application ![]()
| IHC-P, WB, E |
---|---|
Primary Accession | P08590 |
Other Accession | NP_000249.1 |
Reactivity | Human, Rat, Mouse |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | Rabbit IgG |
Calculated MW | 21932 Da |
Antigen Region | 1-30 aa |
Gene ID | 4634 |
---|---|
Other Names | Myosin light chain 3, Cardiac myosin light chain 1, CMLC1, Myosin light chain 1, slow-twitch muscle B/ventricular isoform, MLC1SB, Ventricular/slow twitch myosin alkali light chain, MYL3 |
Target/Specificity | This MYL3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human MYL3. |
Dilution | IHC-P~~1:100~500 WB~~1:1000 E~~Use at an assay dependent concentration. |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | MYL3 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | MYL3 (HGNC:7584) |
---|---|
Function | Regulatory light chain of myosin. Does not bind calcium. |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
MYL3 encodes myosin light chain 3, an alkali light chain also referred to in the literature as both the ventricular isoform and the slow skeletal muscle isoform. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy.
REFERENCES
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)
Girolami, F., et al. J. Am. Coll. Cardiol. 55(14):1444-1453(2010)
Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009)
McLeod, C.J., et al. Am. Heart J. 158(5):799-805(2009)
Kaski, J.P., et al. Circ Cardiovasc Genet 2(5):436-441(2009)

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.